1.
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Bu...
by Abbas, Kaja M
The Lancet (British edition), 2017, Vol.390 (10091), p.231-266
2.
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic anal...
by Charlson, Fiona J
The Lancet (British edition), 2016, Vol.388 (10053), p.1659-1724
3.
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic anal...
by Gakidou, Emmanuela
The Lancet (British edition), 2017-09-16, Vol.390 (10100), p.1345-1422
4.
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013:...
by Burnett, Richard
The Lancet (British edition), 2015, Vol.386 (10010), p.2287-2323
5.
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Globa...
by Vos, Theo, Prof
The Lancet (British edition), 2013, Vol.380 (9859), p.2224-2260
6.
Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study
by Li, Linxin, DPhil
The Lancet (British edition), 2017, Vol.390 (10093), p.490-499
7.
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies
by Schouten, L.J
The Lancet (British edition), 2015, Vol.385 (9980), p.1835-1842
8.
Recommendations for the design of laboratory studies on non-target arthropods for risk assessment of genetically engineered plants
by Romeis, Jörg
Transgenic research, 2010-10-13, Vol.20 (1), p.1-22
9.
Human health risk assessment for arsenic: A critical review
by Rasheed, Hifza
Critical reviews in environmental science and technology, 2016-10-17, Vol.46 (19-20), p.1529-1583
10.
11.
Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study
by Fidler, Miranda M
The lancet oncology, 2017-12, Vol.18 (12), p.1579-1589
12.
Mortality risk attributable to high and low ambient temperature: a multicountry observational study
by Gasparrini, Antonio, Dr
The Lancet (British edition), 2015, Vol.386 (9991), p.369-375
13.
Carcinogenicity of consumption of red and processed meat
by Bouvard, Véronique
The lancet oncology, 2015, Vol.16 (16), p.1599-1600
14.
Social isolation and loneliness as risk factors for the progression of frailty: the English Longitudinal Study of Ageing
by Gale, Catharine R Catharine R
Age and ageing, 2017-12-22, Vol.47 (3), p.392-397
15.
Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies
by Mente, Andrew, Prof
The Lancet (British edition), 2016, Vol.388 (10043), p.465-475
16.
Development of a rational scale to assess the harm of drugs of potential misuse
by Nutt, David, Prof
The Lancet (British edition), 2007, Vol.369 (9566), p.1047-1053
17.
Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, coh...
by Tang, Xin-Ran
The lancet oncology, 2018-03, Vol.19 (3), p.382-393
18.
Socio-Ecological Mechanisms Supporting High Densities of Aedes albopictus (Diptera: Culicidae) in Baltimore, MD
by Little, E
Journal of medical entomology, 2017-06-12, Vol.54 (5), p.1183-1192
19.
Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts
by McDonnell, M J
Thorax, 2016-12, Vol.71 (12), p.1110-1118
20.
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
by Giugliano, Robert P
The Lancet (British edition), 2017-10-28, Vol.390 (10106), p.1962-1971
